+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cerebral Oximetry Monitoring Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 350 Pages
  • July 2025
  • Region: Global
  • Expert Market Research
  • ID: 6163028
The global cerebral oximetry monitoring market size was valued at USD 217.20 Million in 2024, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 7.20% during the forecast period of 2025-2034 to achieve a value of USD 435.32 Million by 2034 .

Cerebral Oximetry Monitoring: Introduction

Cerebral oximeters are non-invasive and continuous monitoring devices that are used to monitor adequate cerebral oxygenation. They utilize similar physical principles to pulse oximeters. Cerebral oximeters are used to measure tissue oxygen saturation, reflecting haemoglobin saturation in arterial, venous, and capillary blood. Cerebral oximetry measures regional tissue saturation in an area of the frontal cortex of nearly 1 cm3. RSO2 values are affected by the physiologic variables that determine brain oxygen supply and demand.

Cerebral oximeters consist of a monitoring device that is paired with oximeter probes, which are affixed to the patient's scalp with adhesive pads. These probes are generally placed over the frontal lobe region of the scalp. They incorporate fibre optic light sources and light detectors that emit infrared light through either stimulated emission of radiation or light-emitting diodes. The resulting light can penetrate the skull and reach the cerebral tissue below.

Global Cerebral Oximetry Monitoring Market Analysis

The market for cerebral oximetry monitoring has been experiencing significant growth and is expected to continue growing in the forecast period as well. The thriving ageing population and an increase in diseases like cardiovascular and neurological disorders is significantly contributing to the cerebral oximetry monitoring device market share.

The Centers for Disease Control and Prevention (CDC) reports that in the United States alone, nearly 697,000 people have coronary artery disease (CAD) due to lifestyle factors such as smoking, alcohol consumption, and physical inactivity. This rise in CAD cases is expected to increase the demand for cerebral oximetry monitoring devices for safe surgeries. The medical sector is continuously developing and adopting these devices, leading to further market growth. Technological advancements are also expected to boost the cerebral oximetry monitoring device market demand.

Additionally, the increased awareness of combining cerebral oximeters with other technologies is a significant factor driving market growth. Cerebral oximetry monitoring has also been increasingly used in extremely preterm infants to guide treatments for conditions such as low systematic blood flow, low cerebral blood flow, and even risk of ischemia. Such fields can potentially increase the demand for cerebral oximetry monitoring further in the market.

Global Cerebral Oximetry Monitoring Market Segmentations

Cerebral Oximetry Monitoring Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Age

  • Adult
  • Pediatric

Market Breakup by Application

  • Cardiac Surgery
  • Vascular Surgery
  • Others

Market Breakup by End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Cerebral Oximetry Monitoring Market Overview

The increasing geriatric population and increasing prevalence of chronic diseases are major factors driving the market growth. The increasing awareness about non-invasive monitoring procedures, which is further contributing to the increased demand for such procedures as cerebral oximetry monitoring, is propelling the market growth. The cerebral oximetry monitoring market growth is also driven by continuous technological advancement. Another factor responsible for the growth of the market is the expanded utilization of cerebral oximetry monitoring in several medical specialties such as neurology, cardiovascular surgeries, and anesthesia, among others.

Geographically, North America is leading the global market and is expected to keep leading in the coming years as well. The presence of some of the major key players offering new innovative products and techniques in the region is also a major factor driving the cerebral oximetry monitoring market demand. Cerebral oximetry monitoring is performed to monitor cerebral desaturation in cardiac surgery. The increasing research activities for developing novel cerebral oximeter devices are directly expected to drive the market growth.

Global Cerebral Oximetry Monitoring Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Medtronic
  • Masimo
  • Edwards Lifesciences Corporation
  • Nonin
  • ISS, Inc.
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Terumo Cardiovascular Systems Corporation
  • Mespere LifeSciences

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cerebral Oximetry Monitoring Market Overview
3.1 Global Cerebral Oximetry Monitoring Market Historical Value (2018-2024)
3.2 Global Cerebral Oximetry Monitoring Market Forecast Value (2025-2034)
4 Global Cerebral Oximetry Monitoring Market Landscape
4.1 Global Cerebral Oximetry Monitoring Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cerebral Oximetry Monitoring Product Landscape
4.2.1 Analysis by Age
4.2.2 Analysis by Application
5 Global Cerebral Oximetry Monitoring Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cerebral Oximetry Monitoring Market Segmentation
6.1 Global Cerebral Oximetry Monitoring Market by Age
6.1.1 Market Overview
6.1.2 Adult
6.1.3 Pediatric
6.2 Global Cerebral Oximetry Monitoring Market by Application
6.2.1 Market Overview
6.2.2 Cardiac Surgery
6.2.3 Vascular Surgery
6.2.4 Others
6.3 Global Cerebral Oximetry Monitoring Market by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Specialty Clinics
6.3.4 Ambulatory Surgical Centers
6.3.5 Others
6.4 Global Cerebral Oximetry Monitoring Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cerebral Oximetry Monitoring Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cerebral Oximetry Monitoring Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cerebral Oximetry Monitoring Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cerebral Oximetry Monitoring Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cerebral Oximetry Monitoring Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Medtronic
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Masimo
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Edwards Lifesciences Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Nonin
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 ISS, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GE Healthcare
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Hamamatsu Photonics K.K.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Terumo Cardiovascular Systems Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Mespere LifeSciences
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
18 Global Cerebral Oximetry Monitoring Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Medtronic
  • Masimo
  • Edwards Lifesciences Corporation
  • Nonin
  • Financial Portfolio
  • ISS, Inc.
  • GE Healthcare
  • Hamamatsu Photonics K.K.
  • Terumo Cardiovascular Systems Corporation
  • Mespere LifeSciences